Get started
Author

Ashmita Chaulagain

ORCID: 0000-0001-5467-181X
Observed ORCID: 0000-0001-5467-181X
OpenAlex ID: A5081914338
A systematic meta-review of systematic reviews on attention deficit hyperactivity disorder
2023 · Ashmita Chaulagain, Ingvild Lyhmann, et al. · European Psychiatry · 97
PDF
Pharmacotherapy of restricted/repetitive behavior in autism spectrum disorder:a systematic review and meta-analysis
2020 · Yanjie Yu, Ashmita Chaulagain, et al. · BMC Psychiatry · 68
PDF
Child and adolescent mental health problems in Nepal: a scoping review
2019 · Ashmita Chaulagain, Arun Kunwar, et al. · International Journal of Mental Health Systems · 62
PDF
WHO Mental Health Gap Action Programme Intervention Guide (mhGAP-IG): the first pre-service training study
2020 · Ashmita Chaulagain, Laura Pacione, et al. · International Journal of Mental Health Systems · 48
PDF
Geographical variation in ADHD: do diagnoses reflect symptom levels?
2022 · Tarjei Widding-Havneraas, Simen Markussen, et al. · European Child & Adolescent Psychiatry · 41
PDF
Preference-based instrumental variables in health research rely on important and underreported assumptions: a systematic review
2021 · Tarjei Widding-Havneraas, Ashmita Chaulagain, et al. · Journal of Clinical Epidemiology · 40
PDF
Causal modelling of variation in clinical practice and long-term outcomes of ADHD using Norwegian registry data: the ADHD controversy project
2021 · Arnstein Mykletun, Tarjei Widding-Havneraas, et al. · BMJ Open · 24
PDF
Effect of Pharmacological Treatment of Attention-Deficit/Hyperactivity Disorder on Criminality
2023 · Tarjei Widding-Havneraas, Henrik Daae Zachrisson, et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 22
PDF
Variation in attitudes toward diagnosis and medication of ADHD: a survey among clinicians in the Norwegian child and adolescent mental health services
2022 · Ingvild Lyhmann, Tarjei Widding-Havneraas, et al. · European Child & Adolescent Psychiatry · 15
PDF
Effect of pharmacological treatment of attention-deficit/hyperactivity disorder on later psychiatric comorbidity: a population-based prospective long-term study
2024 · Ingvild Lyhmann, Tarjei Widding-Havneraas, et al. · BMJ Mental Health · 10
PDF
Effect of ADHD medication on risk of injuries: a preference-based instrumental variable analysis
2023 · Tarjei Widding-Havneraas, Felix Elwert, et al. · European Child & Adolescent Psychiatry · 9
PDF
Drug-Induced Extrapyramidal Symptoms Scale of the Norwegian version: inter-rater and test–retest reliability
2019 · Bernhard Weidle, Ashmita Chaulagain, et al. · Nordic Journal of Psychiatry · 5
Effect of pharmacological treatment of attention-deficit hyperactivity disorder on academic performance: registry-based population study
2026 · Ingvild Lyhmann, Tarjei Widding-Havneraas, et al. · The British Journal of Psychiatry · 1
PDF
Effect of pharmacological treatment of attention–deficit hyperactivity disorder on contacts with child welfare services
2026 · Ashmita Chaulagain, Tarjei Widding-Havneraas, et al. · The British Journal of Psychiatry · 1
PDF
Lifetime Contacts with Child Welfare Services among Children and Adolescents with ADHD: A Population-Based Registry Study
2025 · Ashmita Chaulagain, Tarjei Widding-Havneraas, et al. · Child Psychiatry & Human Development · 1
PDF
Birthweight percentiles by gestational age in Georgia
2017 · Ashmita Chaulagain · NORA - Norwegian Open Research Archives · 1
The ADHD controversy project: Long-term effects of ADHD diagnosis
2020 · Arnstein Mykletun, Tarjei Widding-Havneraas, et al. · http://isrctn.com/
The ADHD controversy project: Long-term effects of ADHD medication
2020 · Arnstein Mykletun, Tarjei Widding-Havneraas, et al. · http://isrctn.com/
Drug-Induced Extrapyramidal Symptoms Scale--Norwegian Version
2019 · Berhard Weide, Ashmita Chaulagain, et al. · PsycTESTS Dataset
Works count: 19
Citation count: 440
H-index: 10
I10-index: 10
Year
Topic
Type